Physician

Matthew Dwight Straesser, MD

According to 2025 Medicare claims, Matthew Straesser, MD (NPI: 1972999340) practices allergy/immunology in the Altoona, PA market, with the plurality of this provider's patient population coming from Blair, PA. This provider's primary affiliated billing organization is CENTRAL PENNSYLVANIA ASTHMA AND ALLERGY CARE, LLC (NPI: 1083730857; TIN: 260216930) and primary practice location at 16648-3050.

Straesser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 12,561 HCPCS/CPT codes, and received $260,916 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,632 prescription claims across 360 beneficiaries totaling $453,053 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). DME data shows 90 claims. Open Payments data shows 2 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,186 to $260,916. Similarly, Part D prescription costs have risen steadily, from $4,713 to $453,053. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $250 and ending at $690.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$130K$261K2020 Medicare payment: $14,186 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $90,798 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $123,864 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $185,519 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $260,916 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020121944$14,186
20212956,368$90,798
20223997,140$123,864
20233919,253$185,519
202439112,561$260,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$227K$453K2015 Drug cost: $4,713 (USD; Tot_Drug_Cst)2016 Drug cost: $27,404 (USD; Tot_Drug_Cst)2017 Drug cost: $59,168 (USD; Tot_Drug_Cst)2018 Drug cost: $44,339 (USD; Tot_Drug_Cst)2019 Drug cost: $60,748 (USD; Tot_Drug_Cst)2020 Drug cost: $99,498 (USD; Tot_Drug_Cst)2021 Drug cost: $138,053 (USD; Tot_Drug_Cst)2022 Drug cost: $233,998 (USD; Tot_Drug_Cst)2023 Drug cost: $321,281 (USD; Tot_Drug_Cst)2024 Drug cost: $453,053 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151682$4,713
201663302$27,404
201797514$59,168
201880391$44,339
201959182$60,748
202079228$99,498
2021204689$138,053
20222691,074$233,998
20232901,287$321,281
20243601,632$453,053

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$84K$167K2019 Medicare payment: $57 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $54 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $26,240 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $209 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $720 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $167,223 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R15$57
2020N/R11$54
2021N/R27$26,240
2022N/R11$209
2023N/R37$720
2024N/R90$167,223

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6464$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more274338$86
94060Test to measure expiratory airflow and volume changes before and after medication administration6680$26
95165Professional service for preparation and provision of 1 or more antigens992,458$10
95117Professional service for multiple injections of allergen83640$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gamunex-CImmune Globul G/Gly/Iga Avg 4613364$76,551
TezspireTezepelumab-Ekko13364$54,876
Trelegy ElliptaFluticasone/Umeclidin/Vilanter702,580$52,924
Dupixent PenDupilumab14378$50,316
NucalaMepolizumab12336$43,027

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R13$106,134
J1555Injection, immune globulin (cuvitru), 100 mgNN/R13$59,925
J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mgNN/R24$729
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R26$418
J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mgNN/R14$16

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$29AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Dwight Straesser, MD?

Tedicare shows public-source Medicare data for Matthew Dwight Straesser, MD (NPI 1972999340), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Dwight Straesser, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Dwight Straesser, MD?

Matthew Dwight Straesser, MD is linked to CENTRAL PENNSYLVANIA ASTHMA AND ALLERGY CARE, LLC (billing NPI 1083730857) in the available physician profile data.

Does Matthew Dwight Straesser, MD have Open Payments data?

Matthew Dwight Straesser, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.